We are live on ! Find out more
TNDM icon

Tandem Diabetes Care
TNDM

116 hedge funds and large institutions have $735M invested in Tandem Diabetes Care in 2018 Q2 according to their latest regulatory filings, with 60 funds opening new positions, 24 increasing their positions, 24 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

595% more capital invested

Capital invested by funds: $106M → $735M (+$630M)

233% more first-time investments, than exits

New positions opened: 60 | Existing positions closed: 18

200% more funds holding in top 10

Funds holding in top 10: 2 → 6 (+4)

85% more call options, than puts

Call options by funds: $22.3M | Put options by funds: $12.1M

55% more funds holding

Funds holding: 75 → 116 (+41)

18.99% more ownership

Funds ownership: 47.71% → 66.7% (+19%)

0% more repeat investments, than reductions

Existing positions increased: 24 | Existing positions reduced: 24

Holders
116
Holders Change
+41
Holders Change %
+54.67%
% of All Funds
2.66%
Holding in Top 10
6
Holding in Top 10 Change
+4
Holding in Top 10 Change %
+200%
% of All Funds
0.14%
New
60
Increased
24
Reduced
24
Closed
18
Calls
$22.3M
Puts
$12.1M
Net Calls
+$10.2M
Net Calls Change
+$5.76M

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$35.6M
2
DM
Deerfield Management
New York
+$27.7M
3
FAM
Fred Alger Management
New York
+$24M
4
O
OrbiMed
New York
+$20.8M
5
Point72 Asset Management
Point72 Asset Management
Connecticut
+$15.2M

Top Sellers

Rank Fund Capital Flow
1
FLAM
First Light Asset Management
Minnesota
-$34.8M
2
ACP
Acuta Capital Partners
California
-$6.68M
3
WA
Wasatch Advisors
Utah
-$4.33M
4
MAG
Millrace Asset Group
Pennsylvania
-$4.18M
5
ACA
Avoro Capital Advisors
New York
-$3.89M
Name Holding Trade Value Shares
Change 		Change in
Stake
GPCM
26
Granite Point Capital Management
Massachusetts
$4.96M +$2.77M +225,000 New
Renaissance Technologies
27
Renaissance Technologies
New York
$4.54M +$604K +49,137 +31%
Bank of New York Mellon
28
Bank of New York Mellon
New York
$4.51M +$1.91M +155,314 +315%
EI
29
EAM Investors
California
$4.41M +$2.46M +200,187 New
WMSA
30
Weiss Multi-Strategy Advisers
New York
$4.07M -$2.64M -215,000 -54%
Citadel Advisors
31
Citadel Advisors
Florida
$4.07M +$2.27M +184,764 New
Deutsche Bank
32
Deutsche Bank
Germany
$3.98M +$663K +53,932 +43%
MAG
33
Millrace Asset Group
Pennsylvania
$3.52M -$4.18M -340,000 -68%
CIP
34
Chartwell Investment Partners
Pennsylvania
$3.38M -$1.28M -103,990 -40%
Adage Capital Partners
35
Adage Capital Partners
Massachusetts
$3.3M +$1.84M +150,000 New
EIM
36
Essex Investment Management
Massachusetts
$3.2M -$1.37M -111,628 -43%
CCS
37
Crosspoint Capital Strategies
California
$2.84M +$1.59M +129,100 New
SIM
38
Spark Investment Management
New York
$2.69M +$98.4K +8,000 +7%
BG
39
Bellevue Group
Switzerland
$2.51M +$1.4M +114,006 New
FA
40
Friess Associates
Delaware
$2.38M +$1.33M +108,000 New
Morgan Stanley
41
Morgan Stanley
New York
$2.25M +$1.04M +84,552 +478%
EGM
42
Engineers Gate Manager
New York
$2.17M +$1.21M +98,761 New
TCIM
43
TIAA CREF Investment Management
New York
$2.15M +$1.2M +97,872 New
KCM
44
Kennedy Capital Management
Missouri
$2.15M -$1.26M -102,104 -51%
Charles Schwab
45
Charles Schwab
California
$2.11M +$1.18M +95,686 New
Two Sigma Advisers
46
Two Sigma Advisers
New York
$2.07M +$1.16M +93,972 New
TA
47
Teachers Advisors
New York
$1.96M +$1.09M +88,945 New
ARTA
48
A.R.T. Advisors
New York
$1.81M +$535K +43,517 +113%
EGI
49
EAM Global Investors
California
$1.73M +$966K +78,538 New
PPA
50
Parametric Portfolio Associates
Washington
$1.56M +$870K +70,787 New
1
2
3 4 5

TNDM Hedge Fund Activity: Q2 2018 in Review

116 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Tandem Diabetes Care (TNDM) for Q2 2018, worth a combined $735M — up 595% from $106M a quarter earlier.

Buyers outnumbered sellers: 60 funds opened new TNDM positions and 18 closed out — a net gain of 42 holders — while 24 added to existing stakes and 24 trimmed.

The largest buyer was BlackRock, adding an estimated $35.6M. The largest seller was First Light Asset Management, cutting an estimated $34.8M.

  • 116 institutional investors held Tandem Diabetes Care (TNDM) as of Q2 2018, up from 75 in Q1 2018.
  • Funds reported $735M of Tandem Diabetes Care stock for Q2 2018, up 595% quarter-over-quarter.
  • 60 funds opened new Tandem Diabetes Care positions in Q2 2018 and 18 closed out, a net change of +42 holders.
  • The largest Tandem Diabetes Care buyer in Q2 2018 was BlackRock, an estimated $35.6M added.
  • The largest Tandem Diabetes Care seller in Q2 2018 was First Light Asset Management, an estimated $34.8M sold.

Based on aggregated 13F filings for Q2 2018.